Nuvation Bio NUVB Fair Value Measurement Disclosure
Fair Value Measurement Disclosure at other companies
Other financials
Where this comes from
Reported directly by Nuvation Bio in its filing.
Tagged under the XBRL concept us-gaap:DerivativeFairValueOfDerivativeLiability.
The official record: Nuvation Bio’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nuvation Bio's fair value measurement disclosure.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nuvation Bio's fair value measurement disclosure?
- Nuvation Bio (NUVB) reported fair value measurement disclosure of $2.87M in Q4 2025.
- How has Nuvation Bio's fair value measurement disclosure changed year-over-year?
- Nuvation Bio's fair value measurement disclosure increased by 39.6% year-over-year, from $2.05M to $2.87M.
- What is the long-term trend for Nuvation Bio's fair value measurement disclosure?
- Over 5 years (2020 to 2025), Nuvation Bio's fair value measurement disclosure has grown at a 1448.3% compound annual growth rate (CAGR), from $3.22 to $2.87M.
- What does fair value measurement disclosure mean?
- This represents the aggregate carrying amount of assets and liabilities that are measured at fair value on a recurring or non-recurring basis. It provides transparency into the valuation techniques and inputs used to determine these values, categorized by the fair value hierarchy. This is critical for asset managers holding diverse investment portfolios.